SKAN Group AG (LTS:0SKN) Capex-to-Revenue : 0.14 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is SKAN Group AG Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

SKAN Group AG's Capital Expenditure for the six months ended in Dec. 2023 was CHF-25.12 Mil. Its Revenue for the six months ended in Dec. 2023 was CHF180.28 Mil.

Hence, SKAN Group AG's Capex-to-Revenue for the six months ended in Dec. 2023 was 0.14.

SKAN Group AG Capex-to-Revenue Historical Data

The historical data trend for SKAN Group AG's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SKAN Group AG Capex-to-Revenue Chart

SKAN Group AG Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Capex-to-Revenue

0.08

0.18

0.10

0.11

SKAN Group AG Semi-Annual Data
	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Capex-to-Revenue	Get a 7-Day Free Trial			0.19	0.13	0.08	0.07	0.14

Competitive Comparison of SKAN Group AG's Capex-to-Revenue

For the Medical Instruments & Supplies subindustry, SKAN Group AG's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SKAN Group AG's Capex-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, SKAN Group AG's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where SKAN Group AG's Capex-to-Revenue falls into.

SKAN Group AG Capex-to-Revenue Calculation

SKAN Group AG's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Revenue	=	- Capital Expenditure	/	Revenue
	=	- (-35.298)	/	320.02
	=	0.11

SKAN Group AG's Capex-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Capex-to-Revenue	=	- Capital Expenditure	/	Revenue
	=	- (-25.122)	/	180.282
	=	0.14

SKAN Group AG (LTS:0SKN) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.

SKAN Group AG Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of SKAN Group AG's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

SKAN Group AG (LTS:0SKN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » SKAN Group AG (LTS:0SKN) » Definitions » Capex-to-Revenue

Comparable Companies

Traded in Other Exchanges

SKANz:UK SKAN:Switzerland

Address

Kreuzstrasse 5, Allschwil, CHE, 4123

Website

https://www.skan.com

SKAN Group AG is a global market and technological company for isolators, cleanroom devices, and decontamination processes for the aseptic production of biopharmaceutical substances. Its core competency is the design and development of process isolators for the aseptic filling of biopharmaceutical products. The company offer its customers process support, services, and consumables. Its products include biological indicators, isolators, Laboratory/cleanroom equipment, laminar flow, safety workbench, and transfer system.

SKAN Group AG (LTS:0SKN) Headlines

No Headlines